ArticleImmunology2025

Clinical C3 Inhibition With AMY-101 Reveals Novel Insights Into IL-8-Driven Inflammation in COVID-19.

Christina Antoniadou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.